Smith & Nephew Plc
(NYSE : SNN)

( )
SNN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DXCMDexCom, Inc. -5.79%381.798.2%$1038.76m
ABTAbbott Laboratories -2.22%89.440.8%$646.15m
BDXBecton, Dickinson & Co. -2.55%233.161.0%$577.08m
DHRDanaher Corp. 0.20%158.570.7%$550.68m
INOInovio Pharmaceuticals, Inc. 2.70%14.466.3%$537.80m
MDTMedtronic Plc 2.57%97.150.6%$517.50m
TMOThermo Fisher Scientific, Inc. -2.28%332.511.0%$509.14m
BSXBoston Scientific Corp. 0.78%36.191.1%$395.76m
ISRGIntuitive Surgical, Inc. -0.30%561.092.4%$344.22m
SYKStryker Corp. 1.08%186.131.3%$341.44m
ALGNAlign Technology, Inc. 1.71%247.906.4%$313.33m
WSTWest Pharmaceutical Services, Inc. -2.65%205.841.6%$272.78m
BAXBaxter International, Inc. -1.63%85.511.8%$224.06m
EWEdwards Lifesciences Corp. -0.75%217.181.2%$209.46m
ZBHZimmer Biomet Holdings, Inc. 2.67%126.691.7%$192.22m

Company Profile

Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded by Thomas James Smith in 1856 and is headquartered in London, the United Kingdom.